EMG
IONS icon

ETF Managers Group’s Ionis Pharmaceuticals IONS Stock Holding History

ETF Managers Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-7,649
Closed -$289K – 710
2022
Q4 		$289K Buy
+7,649
New +$322K 0.01% 443
2021
Q2 		– Sell
-6,975
Closed -$312K – 730
2021
Q1 		$312K Buy
6,975
+938
+16% +$52.3K 0.01% 587
2020
Q4 		$345K Buy
6,037
+679
+13% +$33.8K 0.01% 523
2020
Q3 		$260K Buy
5,358
+265
+5% +$14.7K 0.01% 539
2020
Q2 		$303K Buy
5,093
+1,698
+50% +$94.5K 0.01% 408
2020
Q1 		$164K Buy
3,395
+348
+11% +$19.4K 0.01% 490
2019
Q4 		$184K Buy
3,047
+703
+30% +$41.9K 0.01% 519
2019
Q3 		$138K Buy
2,344
+46
+2% +$3K 0.01% 514
2019
Q2 		$149K Sell
2,298
-949
-29% -$67.1K ﹤0.01% 517
2019
Q1 		$264K Buy
3,247
+291
+10% +$18.8K 0.01% 271
2018
Q4 		$160K Buy
2,956
+402
+16% +$20.5K 0.01% 313
2018
Q3 		$132K Buy
2,554
+268
+12% +$12.6K 0.01% 335
2018
Q2 		$1.3M Buy
2,286
+537
+31% +$23.8K 0.09% 112
2018
Q1 		$74K Buy
1,749
+218
+14% +$11.1K ﹤0.01% 412
2017
Q4 		$75K Buy
1,531
+218
+17% +$12K 0.01% 335
2017
Q3 		$67K Buy
1,313
+109
+9% +$5.71K 0.01% 178
2017
Q2 		$61K Buy
+1,204
New +$56.1K 0.01% 221
2016
Q1 		$26K Buy
+652
New +$26.5K 0.02% 404

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ETF Managers Group's IONS Position: Q1 2023 in Review

ETF Managers Group sold out of Ionis Pharmaceuticals (IONS) in Q1 2023, closing a stake of 7,649 shares — an estimated $289K sold.

ETF Managers Group first reported a position in IONS in Q1 2016 and held it in 18 quarters. The position peaked at $1.3M in Q2 2018. 314 funds tracked by Wall St. Rank hold IONS as of Q1 2023.

  • ETF Managers Group reported no remaining Ionis Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
  • ETF Managers Group sold 7,649 Ionis Pharmaceuticals shares in Q1 2023, an estimated $289K.
  • ETF Managers Group first reported a position in Ionis Pharmaceuticals in Q1 2016 and held it in 18 quarters.
  • ETF Managers Group's Ionis Pharmaceuticals position peaked at $1.3M in Q2 2018.
  • 314 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.